Dark Mode
US National Cancer Expenditure Data
Patient Health Records & Digital Health
Tags and Keywords
Trusted By
"No reviews yet"
Free
About
Quantifies the financial outlay dedicated to cancer treatment across the United States. The data addresses the substantial global concern regarding extravagant treatment costs by detailing the total money spent on treating various cancer types. It provides essential context by segmenting costs according to the phase of care, demographic factors such as age and sex, and observed survival rates.
Columns
- Cost of Cancer Care by Phase of Care: Specifies the allocation of costs based on the treatment phase or the primary site of the cancer (e.g., All Sites, Bladder).
- Cost: Indicates the percentage contribution of a specific category or factor to the overall expenditure.
- Year: The calendar year corresponding to the expenditure data, spanning several years, including 2010 and 2011.
- Sexes: Categorises the data by gender, including records for both sexes and females specifically.
- Ages: Defines the patient age grouping under consideration, typically focusing on all ages.
- Survival Rate: Details the assumptions or observed data related to incidence and survival trends used in cost calculations.
- Percentage: A distinct numerical percentage value linked to specific cost elements or phases.
- Money Spent (Multiple Instances): Numerical values representing the actual expenditure amounts recorded for the specified criteria.
Distribution
The data is provided in a CSV file format, designated as DowloadableDataFull_2011.01.12.csv, with a size of approximately 137.55 kB. The structure consists of nine columns and contains over 1,250 records detailing financial breakdowns and demographic variables.
Usage
This resource is highly suitable for policy analysts, health economists, and researchers focused on the economic implications of major diseases. It is invaluable for tasks such as calculating the national economic burden of cancer, modelling future healthcare spending, or analysing cost efficiency across different treatment phases or patient groups.
Coverage
The data focuses entirely on US Expenditures on Cancer Care. The temporal scope spans multiple years, with detailed records available for 2010 and 2011, among others. Coverage is broad demographically, encompassing all ages and both sexes, with specific data availability depending on the type and phase of cancer treatment.
License
CC0: Public Domain
Who Can Use It
- Public Health Authorities: To develop evidence-based policies for reducing cancer treatment costs and improving access.
- Academic Researchers: For epidemiological studies that correlate financial output with survival outcomes and incidence rates.
- Healthcare Industry Consultants: To understand market trends and assess the financial landscape of oncology services.
Dataset Name Suggestions
- US National Cancer Expenditure Data
- Financial Costs of Cancer Treatment by Care Phase
- American Oncology Spending and Demographics
Attributes
Original Data Source: US National Cancer Expenditure Data
QUALITY